Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, rater-blinded, crossover study comparing the clinical efficacy of Ritalin(®) LA (methylphenidate) treatment in children with attention-deficit hyperactivity disorder under different breakfast conditions over 2 weeks.
Schulz E, Fleischhaker C, Hennighausen K, Heiser P, Haessler F, Linder M, Stollhoff K, Warnke A, Baier M, Klatt J. Schulz E, et al. Among authors: warnke a. Atten Defic Hyperact Disord. 2010 Nov;2(3):133-8. doi: 10.1007/s12402-010-0031-1. Epub 2010 Sep 7. Atten Defic Hyperact Disord. 2010. PMID: 21432599 Clinical Trial.
Pilot study on HTR2A promoter polymorphism, -1438G/A (rs6311) and a nearby copy number variation showed association with onset and severity in early onset obsessive-compulsive disorder.
Walitza S, Bové DS, Romanos M, Renner T, Held L, Simons M, Wewetzer C, Fleischhaker C, Remschmidt H, Warnke A, Grünblatt E. Walitza S, et al. Among authors: warnke a. J Neural Transm (Vienna). 2012 Apr;119(4):507-15. doi: 10.1007/s00702-011-0699-1. Epub 2011 Aug 28. J Neural Transm (Vienna). 2012. PMID: 21874579
Transmission disequilibrium studies in children and adolescents with obsessive-compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway.
Walitza S, Wewetzer C, Gerlach M, Klampfl K, Geller F, Barth N, Hahn F, Herpertz-Dahlmann B, Gössler M, Fleischhaker C, Schulz E, Hebebrand J, Warnke A, Hinney A. Walitza S, et al. Among authors: warnke a. J Neural Transm (Vienna). 2004 Jul;111(7):817-25. doi: 10.1007/s00702-004-0134-y. Epub 2004 Apr 13. J Neural Transm (Vienna). 2004. PMID: 15206000
Family-based association study of serotonergic candidate genes and attention-deficit/hyperactivity disorder in a German sample.
Heiser P, Dempfle A, Friedel S, Konrad K, Hinney A, Kiefl H, Walitza S, Bettecken T, Saar K, Linder M, Warnke A, Herpertz-Dahlmann B, Schäfer H, Remschmidt H, Hebebrand J. Heiser P, et al. Among authors: warnke a. J Neural Transm (Vienna). 2007;114(4):513-21. doi: 10.1007/s00702-006-0584-5. Epub 2006 Nov 10. J Neural Transm (Vienna). 2007. PMID: 17093889
A double-blind, randomized, placebo/active controlled crossover evaluation of the efficacy and safety of Ritalin ® LA in children with attention-deficit/hyperactivity disorder in a laboratory classroom setting.
Schulz E, Fleischhaker C, Hennighausen K, Heiser P, Oehler KU, Linder M, Haessler F, Huss M, Warnke A, Schmidt M, Schulte-Markworth M, Sieder C, Klatt J, Tracik F. Schulz E, et al. Among authors: warnke a. J Child Adolesc Psychopharmacol. 2010 Oct;20(5):377-85. doi: 10.1089/cap.2009.0106. J Child Adolesc Psychopharmacol. 2010. PMID: 20973708 Clinical Trial.
256 results